冠心病合并左心功能不全给予黄芪汤治疗的效果分析
|
摘要
目的探索冠心病合并左心功能不全给予黄芪汤治疗的效果。方法选取2017年3月20日至2018年3月20日本院冠心病合并左心功能不全100例患者(实施奇偶数法分组模式),对照组的50例患者进行常规西医治疗,观察组的50例患者进行黄芪汤治疗。结果观察组VA[(68.49±3.27)cm/s]、VE[(69.87±3.56)cm/s]、SV[(59.86±4.18)ml]、EF[(65.39±4.39)%]、总有效率(94.00%)、LVEDV[(51.48±2.33)ml/m2]、LVEF[(45.59±5.29)%]、神疲乏力[(1.53±0.44)分]、心悸[(0.62±0.13)分]、胸痛[(0.87±0.22)分]、胸闷[(1.32±0.44)分]均优于对照组(P <0.05)。结论黄芪汤用于冠心病合并左心功能不全患者中效果显著。
Objective To explore the effect of Huangqi decoction in the treatment of coronary heart disease complicated with left ventricular dysfunction. Methods 100 patients with coronary heart disease and left ventricular dysfunction in our hospital from March20, 2017 to March 20, 2018 were enrolled in the study, the 50 patients in the control group were treated with conventional Western medicine, 50 patients in the group were treated with Huangqi Decoction. Results Observation group VA[(68.49±3.27) cm/s], VE[(69.87±3.56) cm/s], SV[(59.86±4.18) ml], EF [(65.39±4.39)%], total effective rate(94.00%), LVEDV[( 51.48±2.33) ml/m2], LVEF[(45.59±5.29)%], shenpi fatigue(1.53±0.44), palpitations(0.62±0.13), chest pain(0.87±0.22), chest tightness(1.32±0.44) better than the control group(P<0.05). Conclusion Huangqi decoction is effective in patients with coronary heart disease and left ventricular dysfunction.
Objective To explore the effect of Huangqi decoction in the treatment of coronary heart disease complicated with left ventricular dysfunction. Methods 100 patients with coronary heart disease and left ventricular dysfunction in our hospital from March20, 2017 to March 20, 2018 were enrolled in the study, the 50 patients in the control group were treated with conventional Western medicine, 50 patients in the group were treated with Huangqi Decoction. Results Observation group VA[(68.49±3.27) cm/s], VE[(69.87±3.56) cm/s], SV[(59.86±4.18) ml], EF [(65.39±4.39)%], total effective rate(94.00%), LVEDV[( 51.48±2.33) ml/m2], LVEF[(45.59±5.29)%], shenpi fatigue(1.53±0.44), palpitations(0.62±0.13), chest pain(0.87±0.22), chest tightness(1.32±0.44) better than the control group(P<0.05). Conclusion Huangqi decoction is effective in patients with coronary heart disease and left ventricular dysfunction.
引文
[1]杨园园,赵国良,李达,等.黄芪桂枝五物汤加味治疗冠心病心绞痛的系统评价[J].中西医结合心脑血管病杂志,2018,16(10):1323-1326.
[2]曹敏,周端,尚云,等.黄芪保心汤对冠心病心绞痛病人中医证候积分、血脂及炎症因子的影响[J].中西医结合心脑血管病杂志,2017,15(11):1300-1303.
[3]于圣仕.黄芪桂枝五物汤加味治疗142例冠心病心绞痛患者[J].中西医结合心脑血管病杂志,2015,13(11):1300-1301.
[4]李冀,孙新雨,毕珺辉,等.黄芪桂枝五物汤的临证应用及实验研究进展[J].中医药学报,2014,22(5):108-111.
[5]汤湖波.冠心病心绞痛应用中西医结合治疗的临床效果分析[J].中外健康文摘,2014,27(16):132-132.
[6]齐锋,宋柏奇.补阳还五汤联合西药常规干预治疗冠心病经皮冠状动脉介入术后不稳定性心绞痛气虚血瘀型39例[J].中医研究,2016,29(9):13-15.
[7]颜思阳,彭筱平.黄芪建中汤加减治疗冠心病PCI术后自汗气虚证30例疗效观察[J].湖南中医杂志,2018,34(4):58-59.
[8]杨哲粉.中西医结合治疗老年冠心病心衰效果观察[J].心血管病防治知识,2016,23(4):84-85.
[9]张雯雯,王晶,王连志,等.黄芪汤治疗冠心病合并左心功能不全40例[J].中国中医药现代远程教育,2018,16(14):118-119.
[10]杨广龙.中医药治疗尿毒症合并慢性心功能不全患者低温可调钠透析致低血压26例[J].河南中医,2018,38(2):238-240.
[11]康彦同.中西药联合治疗冠心病的临床观察[J].临床合理用药杂志,2014,21(19):32-33.
[12]张汉明.中西药联合治疗对冠心病患者血浆脑钠肽水平变化的影响[J].临床合理用药杂志,2016,9(17):35-36.
[2]曹敏,周端,尚云,等.黄芪保心汤对冠心病心绞痛病人中医证候积分、血脂及炎症因子的影响[J].中西医结合心脑血管病杂志,2017,15(11):1300-1303.
[3]于圣仕.黄芪桂枝五物汤加味治疗142例冠心病心绞痛患者[J].中西医结合心脑血管病杂志,2015,13(11):1300-1301.
[4]李冀,孙新雨,毕珺辉,等.黄芪桂枝五物汤的临证应用及实验研究进展[J].中医药学报,2014,22(5):108-111.
[5]汤湖波.冠心病心绞痛应用中西医结合治疗的临床效果分析[J].中外健康文摘,2014,27(16):132-132.
[6]齐锋,宋柏奇.补阳还五汤联合西药常规干预治疗冠心病经皮冠状动脉介入术后不稳定性心绞痛气虚血瘀型39例[J].中医研究,2016,29(9):13-15.
[7]颜思阳,彭筱平.黄芪建中汤加减治疗冠心病PCI术后自汗气虚证30例疗效观察[J].湖南中医杂志,2018,34(4):58-59.
[8]杨哲粉.中西医结合治疗老年冠心病心衰效果观察[J].心血管病防治知识,2016,23(4):84-85.
[9]张雯雯,王晶,王连志,等.黄芪汤治疗冠心病合并左心功能不全40例[J].中国中医药现代远程教育,2018,16(14):118-119.
[10]杨广龙.中医药治疗尿毒症合并慢性心功能不全患者低温可调钠透析致低血压26例[J].河南中医,2018,38(2):238-240.
[11]康彦同.中西药联合治疗冠心病的临床观察[J].临床合理用药杂志,2014,21(19):32-33.
[12]张汉明.中西药联合治疗对冠心病患者血浆脑钠肽水平变化的影响[J].临床合理用药杂志,2016,9(17):35-36.